In Vitro and In Vivo Diagnostic Substances - Insider Trading Data

Insiders are officers, directors, or significant investors. This page shows insider sentiment and transactions for the In industry. Research shows that insider trades are predictive of future stock returns. By examining insider trades for an industry, we can understand what well-informed people think of the overall future industry prospects.

In Vitro and In Vivo Diagnostic Substances - Insider Buy/Sell Ratio

Insider selling and buying is a useful indicator for analyzing the market because it serves as a proxy for their optimism or pessimism in their own companies. By looking at ratio of total selling and buying across the entire market, we might be able to draw some conclusions about the future market.

We offer two charts here. The first one shows the total dollar volume of buying and selling by insiders. The second chart shows the ratio of the number of insiders selling, vs. the number of insiders buying. In both charts, we filter out trades made by indirect holders (such as trusts), and 10% owners (who, although considered an 'insider' by the SEC, do not actually manage the companies in which they are considered insiders).

Corporate Insider Buy Sell Ratio (Dollar Volume) - In Vitro and In Vivo Diagnostic Substances
Corporate Insider Buy Sell Ratio (Insider Count) - In Vitro and In Vivo Diagnostic Substances
In Vitro and In Vivo Diagnostic Substances - Transaction History

Click the link icon to see the full transaction history. Transactions reported as part of a 10b5-1 automatic trading plan will have an X in the column marked 10b-5.

Tran
Date
Security Form Insider Code 10b5-1 Direct Share
Price
Shares
Changed
2025-10-31 IMDX / Insight Molecular Diagnostics Inc. 4/A James Andrea S. F - Taxes D 6.01 -12,175
2025-10-30 IDXX / IDEXX Laboratories, Inc. 4 HOOLEY JOSEPH L A - Award D 628.54 39
2025-10-27 NEOG / Neogen Corporation 4 CAPELLO JEFFREY D M - Exercise D 6.19 1,777
2025-10-27 NEOG / Neogen Corporation 4 Rocklin Amy M M - Exercise D 6.19 9,474
2025-10-27 NEOG / Neogen Corporation 4 RODRIGUEZ RAFAEL A M - Exercise D 6.19 1,777
2025-10-27 NEOG / Neogen Corporation 4 Jones Douglas Edward M - Exercise D 6.19 15,504
2025-10-27 NEOG / Neogen Corporation 4 BOREL JAMES C M - Exercise D 6.19 1,777
2025-10-27 NEOG / Neogen Corporation 4 Naemura David H. M - Exercise D 6.19 15,504
2025-10-27 NEOG / Neogen Corporation 4 ADENT JOHN EDWARD M - Exercise D 6.19 38,759
2025-10-27 NEOG / Neogen Corporation 4 Woteki Catherine E M - Exercise D 6.19 1,777
2025-10-27 NEOG / Neogen Corporation 4 BOREL JAMES C M - Exercise D 6.19 2,025
2025-10-27 NEOG / Neogen Corporation 4 BOEHM WILLIAM T M - Exercise D 6.07 3,553
2025-10-27 NEOG / Neogen Corporation 4 CAPELLO JEFFREY D M - Exercise D 6.19 2,025
2025-10-27 NEOG / Neogen Corporation 4 Tobin James P M - Exercise D 6.19 1,777
2025-10-27 NEOG / Neogen Corporation 4 Green Ronald D M - Exercise D 6.19 1,777
2025-10-27 NEOG / Neogen Corporation 4 Gupta Aashima M - Exercise D 6.19 1,777
2025-10-27 NEOG / Neogen Corporation 4 Naemura David H. F - Taxes D 6.19 -4,261
2025-10-27 NEOG / Neogen Corporation 4 ADENT JOHN EDWARD F - Taxes D 6.19 -8,527
2025-10-27 NEOG / Neogen Corporation 4 Rocklin Amy M F - Taxes D 6.19 -2,085
2025-10-27 NEOG / Neogen Corporation 4 Jones Douglas Edward F - Taxes D 6.19 -3,481
2025-10-24 NEOG / Neogen Corporation 4 Pelossof Avi A - Award D 6.19 19,386
2025-10-23 NEOG / Neogen Corporation 4 Wainer Andrea F A - Award D 6.07 19,769
2025-10-23 NEOG / Neogen Corporation 4 Gupta Aashima A - Award D 6.07 19,769
2025-10-23 NEOG / Neogen Corporation 4 BOREL JAMES C A - Award D 6.07 19,769
2025-10-23 NEOG / Neogen Corporation 4 Woteki Catherine E A - Award D 6.07 19,769
2025-10-23 NEOG / Neogen Corporation 4 CAPELLO JEFFREY D A - Award D 6.07 19,769
2025-10-23 NEOG / Neogen Corporation 4 RODRIGUEZ RAFAEL A A - Award D 6.07 19,769
2025-10-23 NEOG / Neogen Corporation 4 Green Ronald D A - Award D 6.07 19,769
2025-10-23 NEOG / Neogen Corporation 4 Bernard Thierry A - Award D 6.07 19,769
2025-10-14 VNRX / VolitionRx Limited 4 STILL TIMOTHY I P - Purchase D 0.51 48,076
2025-10-14 VNRX / VolitionRx Limited 4 Reynolds Cameron John P - Purchase D 0.51 110,000
2025-10-14 VNRX / VolitionRx Limited 4 Innes Guy Archibald P - Purchase D 0.51 96,153
2025-10-13 NEOG / Neogen Corporation 4 Rocklin Amy M M - Exercise D 6.04 294
2025-10-13 NEOG / Neogen Corporation 4 Jones Douglas Edward M - Exercise D 6.04 783
2025-10-13 NEOG / Neogen Corporation 4 ADENT JOHN EDWARD M - Exercise D 6.04 3,063
2025-10-13 NEOG / Neogen Corporation 4 Jones Douglas Edward F - Taxes D 6.04 -383
2025-10-13 NEOG / Neogen Corporation 4 ADENT JOHN EDWARD F - Taxes D 6.04 -865
2025-10-13 NEOG / Neogen Corporation 4 Rocklin Amy M F - Taxes D 6.04 -115
2025-10-07 NEOG / Neogen Corporation 4 Jones Douglas Edward M - Exercise D 5.63 12,940
2025-10-07 NEOG / Neogen Corporation 4 Gupta Aashima M - Exercise D 5.63 2,071
2025-10-07 NEOG / Neogen Corporation 4 Woteki Catherine E M - Exercise D 5.63 2,071
2025-10-07 NEOG / Neogen Corporation 4 CAPELLO JEFFREY D M - Exercise D 5.63 2,071
2025-10-07 NEOG / Neogen Corporation 4 RODRIGUEZ RAFAEL A M - Exercise D 5.63 2,071
2025-10-07 NEOG / Neogen Corporation 4 Tobin James P M - Exercise D 5.63 2,071
2025-10-07 NEOG / Neogen Corporation 4 ADENT JOHN EDWARD M - Exercise D 5.63 32,936
2025-10-07 NEOG / Neogen Corporation 4 BOREL JAMES C M - Exercise D 5.63 2,071
2025-10-07 NEOG / Neogen Corporation 4 Rocklin Amy M M - Exercise D 5.36 9,036
2025-10-07 NEOG / Neogen Corporation 4 Green Ronald D M - Exercise D 5.63 2,071
2025-10-07 NEOG / Neogen Corporation 4 BOEHM WILLIAM T M - Exercise D 5.63 2,071
2025-10-07 NEOG / Neogen Corporation 4 ADENT JOHN EDWARD F - Taxes D 5.63 -9,297
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)